Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis

Introduction/AimsMyasthenia Gravis (MG) is a common neuromuscular junction disorder that is primarily mediated by anti-acetylcholine receptor antibodies (AChR-Ab). However, using AChR-Ab titers to predict MG severity and improvement remains controversial. This study aims to explore the relationship...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lijun Luo, Xinyi Zhu, Chunbei Wen, Yifan Guo, Jie Yang, Dongsheng Wei, Ping Yu, Mei Wan
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-01-01
Col·lecció:	Frontiers in Neurology
Matèries:	Myasthenia Gravis acetylcholine receptor antibody titers Myasthenia Gravis disease severity score Myasthenia Gravis activities of daily living scale score biomarker
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1506845/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!